InsidersTradesSigma
Total declarations
Companies
▲ Purchases (15 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
15
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-14.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Commodore Capital Lp. Insider active across 5 companies, notably Satsuma Pharmaceuticals, Inc.. Aggregated, 17 disclosures have been recorded. Breakdown: 15 buys · 2 sells. Total volume traded: €27.4m. History available since 15 October 2021. The latest transaction was disclosed on 10 January 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Commodore Capital Lp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
1,050,000 shares@ US$18.0073.5% of flowClass A Common StockSEC:0001493152-24-002290:0
775,756 shares@ €21.0421100.0% of flowCommon StockSEC:0001493152-23-027352:0
Canonical exit: 5 Nov 2023 (T+90)
448,217 shares@ US$15.16926.5% of flowClass A Common StockSEC:0001493152-23-022130:0
Canonical exit: 18 Sept 2023 (T+90)
621.75 shares@ US$22.072100.0% of flowCommon stock, par value $0.001 per shareSEC:0001493152-23-006118:0
Canonical exit: 24 May 2023 (T+90)
8,194 shares@ US$5.249100.0% of flowCommon stock, par value $0.001 per shareSEC:0001493152-23-005870:0
Canonical exit: 22 May 2023 (T+90)
3,250,000 shares@ US$0.70641.1% of flowCommon Stock, par value $0.0001 per shareSEC:0001493152-22-032622:0
2,922 shares@ US$5.420.4% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001545:0
Canonical exit: 22 Feb 2022 (T+90)
3,225 shares@ US$5.440.4% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001523:0
Canonical exit: 17 Feb 2022 (T+90)
9,622 shares@ US$5.851.3% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001471:0
Canonical exit: 8 Feb 2022 (T+90)
560 shares@ US$5.990.1% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001460:0
Canonical exit: 6 Feb 2022 (T+90)
1,400 shares@ US$5.880.2% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001450:0
Canonical exit: 2 Feb 2022 (T+90)
8,880 shares@ US$5.641.1% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001430:0
Canonical exit: 31 Jan 2022 (T+90)
44,651 shares@ US$5.715.7% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001420:0
Canonical exit: 27 Jan 2022 (T+90)
39,581 shares@ US$5.454.9% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001408:0
Canonical exit: 25 Jan 2022 (T+90)
32,816 shares@ US$5.404.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001391:0
Canonical exit: 19 Jan 2022 (T+90)
87,580 shares@ US$5.0710.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001384:0
Canonical exit: 17 Jan 2022 (T+90)
126,000 shares@ US$4.8313.8% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001373:0
Canonical exit: 13 Jan 2022 (T+90)
17 of 17 declarations
About Commodore Capital Lp
COMMODORE CAPITAL LP is a declarant with 17 filings in total. In the recent filings covered, buys amount to EUR 7873772 and sells to EUR 19509531, over the period from 2021-10-19 to 2024-01-12. The companies mentioned are Satsuma Pharmaceuticals, Inc., Vera Therapeutics, Inc., VistaGen Therapeutics, Inc., Enliven Therapeutics, Inc. and IMARA Inc., and the modal transaction nature is Acquisition.
